» Articles » PMID: 31986951

Role of MicroRNA-21 and MicroRNA-155 As Biomarkers for Bronchial Asthma

Overview
Journal Innate Immun
Publisher Sage Publications
Date 2020 Jan 29
PMID 31986951
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA (miRNA)-21 and miRNA-155 are important regulators of gene expression of different immunological molecules. This study aimed to investigate the role of miRNA-21 and miRNA-155 as biomarkers in asthma by comparing their serum expression levels in asthmatic patients to those in healthy controls and correlating their levels with serum IL-4. The expression levels of miRNA-21 and miRNA-155 were evaluated by quantitative RT-PCR. Serum levels of IL-4 were determined using ELISA. Asthmatic patients showed significantly higher serum miRNA-21 and miRNA-155 expression levels compared to controls. A statistically significant positive correlation between the expression levels of miRNA-21 and IL-4 serum levels in asthmatic patients was detected. Nonetheless, no correlation was detected between miRNA-155 expression and each of IL-4 and miRNA-21. A receiver operating characteristic curve analysis showed that at a cut-off value of 1.37, the sensitivity of miRNA-21 as an asthma biomarker was 100% and the specificity was 95%. At a cut-off value of 1.96, the sensitivity of miRNA-155 as an asthma biomarker was 100% and the specificity was 100%. It can be concluded that miRNA-21 and miRNA-155 are potential non-invasive biomarkers in the diagnosis of eosinophilic asthma and its response to therapy.

Citing Articles

Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools.

Kanannejad Z, Arab S, Soleimanian S, Mazare A, Kheshtchin N Immun Inflamm Dis. 2024; 12(6):e1325.

PMID: 38934401 PMC: 11209551. DOI: 10.1002/iid3.1325.


The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosis.

Mohammed O, Doghish A, Alamri M, Alharthi M, Alfaifi J, Adam M Heliyon. 2024; 10(6):e27694.

PMID: 38509956 PMC: 10950666. DOI: 10.1016/j.heliyon.2024.e27694.


The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D Supplementation.

Hernandez-DiazCouder A, Romero-Nava R, Del-Rio-Navarro B, Sanchez-Munoz F, Guzman-Martin C, Reyes-Noriega N Nutrients. 2024; 16(3).

PMID: 38337625 PMC: 10856766. DOI: 10.3390/nu16030341.


Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process.

Savin I, Zenkova M, Senkova A Int J Mol Sci. 2023; 24(22).

PMID: 38003234 PMC: 10671561. DOI: 10.3390/ijms242216042.


Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From -Induced Respiratory Disease to COVID-19 and Beyond.

Wang Y, Zou M, Zhao Y, Kabir M, Peng X Cells. 2023; 12(19).

PMID: 37830635 PMC: 10571955. DOI: 10.3390/cells12192421.


References
1.
Nana-Sinkam S, Hunter M, Nuovo G, Schmittgen T, Gelinas R, Galas D . Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med. 2008; 179(1):4-10. PMC: 2615660. DOI: 10.1164/rccm.200807-1042PP. View

2.
Lee Y, Lee K, Lee H, Rhee Y . Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J Asthma. 2002; 38(8):665-71. DOI: 10.1081/jas-100107544. View

3.
Cui A, Zhao J, Liu S, Hao Y . Associations of IL-4, IL-6, and IL-12 levels in peripheral blood with lung function, cellular immune function, and quality of life in children with moderate-to-severe asthma. Medicine (Baltimore). 2017; 96(12):e6265. PMC: 5371444. DOI: 10.1097/MD.0000000000006265. View

4.
Wu X, Wang M, Zhu H, Tang S, You Y, Xie Y . Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma. Int J Clin Exp Med. 2014; 7(5):1307-12. PMC: 4073748. View

5.
Lu T, Hartner J, Lim E, Fabry V, Mingler M, Cole E . MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011; 187(6):3362-73. PMC: 3175642. DOI: 10.4049/jimmunol.1101235. View